Edgewell Personal Care Company

NYSE:EPC Stock Report

Market Cap: US$1.7b

Edgewell Personal Care Valuation

Is EPC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of EPC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: EPC ($34.73) is trading below our estimate of fair value ($72.63)

Significantly Below Fair Value: EPC is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for EPC?

Key metric: As EPC is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for EPC. This is calculated by dividing EPC's market cap by their current earnings.
What is EPC's PE Ratio?
PE Ratio17.2x
EarningsUS$98.60m
Market CapUS$1.69b

Price to Earnings Ratio vs Peers

How does EPC's PE Ratio compare to its peers?

The above table shows the PE ratio for EPC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average24.2x
OLPX Olaplex Holdings
27.3x3.7%US$1.2b
HKHC Horizon Kinetics Holding
37.7xn/aUS$722.1m
HLF Herbalife
9.2x50.6%US$799.3m
ODD Oddity Tech
22.4x18.5%US$2.3b
EPC Edgewell Personal Care
17.2x18.8%US$1.7b

Price-To-Earnings vs Peers: EPC is good value based on its Price-To-Earnings Ratio (17.2x) compared to the peer average (24.2x).


Price to Earnings Ratio vs Industry

How does EPC's PE Ratio compare vs other companies in the US Personal Products Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
NEPT.F Neptune Wellness Solutions
n/an/aUS$4.00
No more companies available in this PE range
EPC 17.2xIndustry Avg. 26.5xNo. of Companies4PE01632486480+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: EPC is good value based on its Price-To-Earnings Ratio (17.2x) compared to the North American Personal Products industry average (26.5x).


Price to Earnings Ratio vs Fair Ratio

What is EPC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EPC PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.2x
Fair PE Ratio25.1x

Price-To-Earnings vs Fair Ratio: EPC is good value based on its Price-To-Earnings Ratio (17.2x) compared to the estimated Fair Price-To-Earnings Ratio (25.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst EPC forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$34.73
US$41.88
+20.6%
13.4%US$53.00US$35.00n/a8
Nov ’25US$35.07
US$42.00
+19.8%
15.7%US$53.00US$35.00n/a8
Oct ’25US$35.98
US$44.13
+22.6%
14.5%US$53.00US$35.00n/a8
Sep ’25US$40.22
US$44.50
+10.6%
14.1%US$53.00US$35.00n/a8
Aug ’25US$39.26
US$44.88
+14.3%
13.4%US$53.00US$35.00n/a8
Jul ’25US$40.02
US$44.75
+11.8%
13.7%US$53.00US$35.00n/a8
Jun ’25US$38.58
US$44.63
+15.7%
13.9%US$53.00US$35.00n/a8
May ’25US$37.53
US$43.88
+16.9%
15.1%US$53.00US$34.00n/a8
Apr ’25US$37.83
US$44.25
+17.0%
14.3%US$53.00US$34.00n/a8
Mar ’25US$38.05
US$44.25
+16.3%
14.3%US$53.00US$34.00n/a8
Feb ’25US$37.64
US$43.11
+14.5%
15.3%US$53.00US$33.00n/a9
Jan ’25US$36.63
US$42.56
+16.2%
16.9%US$53.00US$32.00n/a9
Dec ’24US$35.07
US$43.00
+22.6%
16.7%US$53.00US$32.00n/a9
Nov ’24US$34.95
US$43.78
+25.3%
15.4%US$53.00US$32.00US$35.079
Oct ’24US$36.96
US$46.22
+25.1%
11.7%US$53.00US$37.00US$35.989
Sep ’24US$39.12
US$46.78
+19.6%
11.7%US$53.00US$37.00US$40.229
Aug ’24US$39.46
US$46.44
+17.7%
12.4%US$53.00US$36.00US$39.269
Jul ’24US$41.31
US$47.56
+15.1%
10.6%US$53.00US$38.00US$40.029
Jun ’24US$40.08
US$47.90
+19.5%
10.2%US$53.00US$38.00US$38.5810
May ’24US$43.57
US$46.30
+6.3%
12.5%US$53.00US$35.00US$37.5310
Apr ’24US$42.42
US$46.22
+9.0%
13.2%US$53.00US$35.00US$37.839
Mar ’24US$42.62
US$46.22
+8.5%
13.2%US$53.00US$35.00US$38.059
Feb ’24US$43.53
US$44.33
+1.8%
12.6%US$53.00US$35.00US$37.649
Jan ’24US$38.54
US$44.00
+14.2%
13.6%US$53.00US$35.00US$36.639
Dec ’23US$42.35
US$43.89
+3.6%
13.5%US$53.00US$35.00US$35.079
Nov ’23US$39.39
US$42.75
+8.5%
15.6%US$53.00US$31.00US$34.958

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies